母牛胆小鬼 发表于 2025-3-21 18:38:13
书目名称Cancer Nanotechnology影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221158<br><br> <br><br>书目名称Cancer Nanotechnology读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221158<br><br> <br><br>向外才掩饰 发表于 2025-3-21 22:10:50
http://reply.papertrans.cn/23/2212/221158/221158_2.png易弯曲 发表于 2025-3-22 03:31:31
Ângela Maria Almeida de Sousa,Christiane Pienna SoPresents a comprehensive overview of different areas of cancer nanotechnology.Addresses a broad spectrum of cutting-edge topics about materials in cancer nanotechnology.Provides students and traineesOffstage 发表于 2025-3-22 05:21:47
http://image.papertrans.cn/c/image/221158.jpgHectic 发表于 2025-3-22 12:40:30
http://reply.papertrans.cn/23/2212/221158/221158_5.png名义上 发表于 2025-3-22 13:24:50
G. Sarosy,L. Rubinstein,B. Leyland-Jones low selectivity toward tumor cells, since they also act on healthy tissues. Theranostics is a new field of nanomedicine, combining therapy, diagnosis, and real-time monitoring using imaging techniques. It is useful to monitor the biodistribution of the chemotherapeutic agent that can be activated i名义上 发表于 2025-3-22 18:50:01
http://reply.papertrans.cn/23/2212/221158/221158_7.png冒烟 发表于 2025-3-23 00:17:51
https://doi.org/10.1007/978-3-642-83405-9 been strictly connected to the need of fabricating organ substitutes with minimal biological functionality for organ transplant’s purpose. In the latest years, thanks to the technological advances in biomaterial fields, bioprinting promoted the development of tissue constructs with biological funct柔声地说 发表于 2025-3-23 02:24:55
UICC International Union Against Cancerting in fewer side effects. With the rise of genetic engineering, recombinant human or humanized mAbs are available in the market for the treatment of cancer, either in monotherapy, in association or conjugated with other drugs. Thus, monovalent or bispecific mAbs find applicability for their antituCongestion 发表于 2025-3-23 07:18:07
http://reply.papertrans.cn/23/2212/221158/221158_10.png